{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 2747, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": "Features company logo and date.", "imagePath": "https://imgproxy.kitesheet.com/AGTXSNKZwGYRlDML9gXuawj0rdXOsI92q8fG1aUyVIw/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iZDY0NzU1YzlkMDk0ZGNlODYyZWM3N2NmYjJiMTk3OC9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/1", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/6SgiuxD0R9Af6iHzinauFkqy_MnxEgKg9j5ZqTNPOYY/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iZDY0NzU1YzlkMDk0ZGNlODYyZWM3N2NmYjJiMTk3OC9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/d0rtfxlO2F-IxJrA9uD6KPcSOhqsDuegcTvmc5wts4c/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iZDY0NzU1YzlkMDk0ZGNlODYyZWM3N2NmYjJiMTk3OC9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/hx8zmDr3-ca_67J4UgFiDcwI1-gEzjeqhRT1Pr8qkVY/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iZDY0NzU1YzlkMDk0ZGNlODYyZWM3N2NmYjJiMTk3OC9wMDAxLnBuZw" }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/2", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "appendix_data", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/3", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a stylized 'T' graphic with a timeline-like bullet structure.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/4", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "team_bio", "function": "other", "notes": "The slide uses a grid layout to present 12 team members with headshots, names, titles, and logos of past/associated organizations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/5", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 5, "beatId": "bdcad09d-f917-4c64-b990-abc26a84ab70", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Team", "beatSlug": "sequoia-pitch-team", "evidence": "The document presents information on TScan Therapeutics' team.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a process flow to explain the 'Learning' phase of their technology platform.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/6", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-6", "loopMatches": [ { "to": 19, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "af0b626c-c83f-46d7-8946-9b828a4fc0e6", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "objective": "Why is TScan Therapeutics' multiplexed TCR-T therapy a good solution for patients with cancer?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "b1431f82-1cfa-496e-bf51-8dcfe1b966ab", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "solution", "function": "present_solution", "notes": "The slide title is likely a continuation from a previous slide (e.g., '...to treat patients who are not eligible for standard therapies').", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/7", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-7", "loopMatches": [ { "to": 19, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "af0b626c-c83f-46d7-8946-9b828a4fc0e6", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "objective": "Why is TScan Therapeutics' multiplexed TCR-T therapy a good solution for patients with cancer?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "b1431f82-1cfa-496e-bf51-8dcfe1b966ab", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "solution", "function": "present_solution", "notes": "Uses a before-after-bridge style logic to illustrate the clinical advantage of multiplexing.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/8", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-8", "loopMatches": [ { "to": 19, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "af0b626c-c83f-46d7-8946-9b828a4fc0e6", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "objective": "Why is TScan Therapeutics' multiplexed TCR-T therapy a good solution for patients with cancer?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "b1431f82-1cfa-496e-bf51-8dcfe1b966ab", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a Gantt-style visualization to show the current development stage of multiple drug candidates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/9", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-9", "loopMatches": [ { "to": 19, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "af0b626c-c83f-46d7-8946-9b828a4fc0e6", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "objective": "Why is TScan Therapeutics' multiplexed TCR-T therapy a good solution for patients with cancer?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "b1431f82-1cfa-496e-bf51-8dcfe1b966ab", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "timeline", "function": "plan_implementation", "notes": "The slide uses a color-coded legend to distinguish between liquid and solid tumor programs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/10", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-10", "loopMatches": [ { "to": 19, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "af0b626c-c83f-46d7-8946-9b828a4fc0e6", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "objective": "Why is TScan Therapeutics' multiplexed TCR-T therapy a good solution for patients with cancer?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "b1431f82-1cfa-496e-bf51-8dcfe1b966ab", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/11", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-11", "loopMatches": [ { "to": 19, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "af0b626c-c83f-46d7-8946-9b828a4fc0e6", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "objective": "Why is TScan Therapeutics' multiplexed TCR-T therapy a good solution for patients with cancer?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "b1431f82-1cfa-496e-bf51-8dcfe1b966ab", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "solution", "function": "present_solution", "notes": "Uses a before-after-bridge framework to contrast current therapy limitations with TScan's solution.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/12", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-12", "loopMatches": [ { "to": 19, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "af0b626c-c83f-46d7-8946-9b828a4fc0e6", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "objective": "Why is TScan Therapeutics' multiplexed TCR-T therapy a good solution for patients with cancer?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "b1431f82-1cfa-496e-bf51-8dcfe1b966ab", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a process flow diagram to explain a proprietary biotechnology platform.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/13", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-13", "loopMatches": [ { "to": 19, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "af0b626c-c83f-46d7-8946-9b828a4fc0e6", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "objective": "Why is TScan Therapeutics' multiplexed TCR-T therapy a good solution for patients with cancer?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "b1431f82-1cfa-496e-bf51-8dcfe1b966ab", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a Venn diagram to explain the scope of their target discovery platform.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/14", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-14", "loopMatches": [ { "to": 19, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "af0b626c-c83f-46d7-8946-9b828a4fc0e6", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "objective": "Why is TScan Therapeutics' multiplexed TCR-T therapy a good solution for patients with cancer?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "b1431f82-1cfa-496e-bf51-8dcfe1b966ab", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "product_demo", "function": "present_solution", "notes": "The chart demonstrates the specificity of the TargetScan platform by highlighting MAGE-A3 as the primary target with significantly higher fold-enrichment.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/15", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-15", "loopMatches": [ { "to": 19, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "af0b626c-c83f-46d7-8946-9b828a4fc0e6", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "objective": "Why is TScan Therapeutics' multiplexed TCR-T therapy a good solution for patients with cancer?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "b1431f82-1cfa-496e-bf51-8dcfe1b966ab", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "product_demo", "function": "present_solution", "notes": "The chart displays fold-enrichment vs protein fragment number, identifying specific gene targets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/16", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-16", "loopMatches": [ { "to": 19, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "af0b626c-c83f-46d7-8946-9b828a4fc0e6", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "objective": "Why is TScan Therapeutics' multiplexed TCR-T therapy a good solution for patients with cancer?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "b1431f82-1cfa-496e-bf51-8dcfe1b966ab", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "solution", "function": "present_solution", "notes": "The slide illustrates a dual-platform approach to TCR discovery and validation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/17", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-17", "loopMatches": [ { "to": 19, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "af0b626c-c83f-46d7-8946-9b828a4fc0e6", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "objective": "Why is TScan Therapeutics' multiplexed TCR-T therapy a good solution for patients with cancer?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "b1431f82-1cfa-496e-bf51-8dcfe1b966ab", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a flow-chart style diagram to position TScan's technology as an evolution of current standard-of-care cell therapies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/18", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-18", "loopMatches": [ { "to": 19, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "af0b626c-c83f-46d7-8946-9b828a4fc0e6", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "objective": "Why is TScan Therapeutics' multiplexed TCR-T therapy a good solution for patients with cancer?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "b1431f82-1cfa-496e-bf51-8dcfe1b966ab", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/19", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-19", "loopMatches": [ { "to": 19, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "af0b626c-c83f-46d7-8946-9b828a4fc0e6", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "objective": "Why is TScan Therapeutics' multiplexed TCR-T therapy a good solution for patients with cancer?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 19, "from": 6, "beatId": "b1431f82-1cfa-496e-bf51-8dcfe1b966ab", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents a comprehensive overview of TScan Therapeutics' solution, including its proprietary TCR-T pipeline and TargetScan platform.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "why_now", "function": "frame_problem", "notes": "Uses a Who/Why/When framework to define the market opportunity.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/20", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-20", "loopMatches": [ { "to": 22, "from": 20, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "becd6f83-d37d-46f9-a0e0-b7ce2b7976e8", "evidence": "The document presents a clear problem statement and market sizing, highlighting the need for effective cancer therapies.", "position": 0, "objective": "What is the cost of inaction for patients with cancer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 22, "from": 20, "beatId": "7130cea9-e445-4d6c-813d-cefc1a9760e1", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The document presents a clear problem statement and market sizing.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The chart shows a clear upward trend in HCT procedures from 2000 to 2018, segmented by indication (AML, MDS, ALL).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/21", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-21", "loopMatches": [ { "to": 22, "from": 20, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "becd6f83-d37d-46f9-a0e0-b7ce2b7976e8", "evidence": "The document presents a clear problem statement and market sizing, highlighting the need for effective cancer therapies.", "position": 0, "objective": "What is the cost of inaction for patients with cancer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 22, "from": 20, "beatId": "7130cea9-e445-4d6c-813d-cefc1a9760e1", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The document presents a clear problem statement and market sizing.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "problem_statement", "function": "frame_problem", "notes": "Uses a process flow diagram to show the patient journey and the specific point of failure (relapse).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/22", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-22", "loopMatches": [ { "to": 22, "from": 20, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "becd6f83-d37d-46f9-a0e0-b7ce2b7976e8", "evidence": "The document presents a clear problem statement and market sizing, highlighting the need for effective cancer therapies.", "position": 0, "objective": "What is the cost of inaction for patients with cancer?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 22, "from": 20, "beatId": "7130cea9-e445-4d6c-813d-cefc1a9760e1", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The document presents a clear problem statement and market sizing.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a circular process flow to show the interaction between the patient's condition and the donor-derived TCR therapy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/23", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "solution", "function": "present_solution", "notes": "The slide shows three distinct charts: a time-course line graph, a bar chart for survival at 90 hours, and a bar chart comparing cell viability across different HA-1 genotypes in AML and ALL cell lines.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/24", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 35, "from": 24, "beatId": "63bd9bf8-a080-4478-9c52-bca8cada4ac8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The document presents data on TScan Therapeutics' progress, including in vitro studies and discovery process.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "product_demo", "function": "present_solution", "notes": "The slide uses microscopy imagery to demonstrate therapeutic efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/25", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-25", "loopMatches": [], "arcBeatMatches": [ { "to": 35, "from": 24, "beatId": "63bd9bf8-a080-4478-9c52-bca8cada4ac8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The document presents data on TScan Therapeutics' progress, including in vitro studies and discovery process.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "solution", "function": "present_solution", "notes": "The chart shows a scatter plot where the vast majority of data points are at zero, indicating no off-target binding.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/26", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-26", "loopMatches": [], "arcBeatMatches": [ { "to": 35, "from": 24, "beatId": "63bd9bf8-a080-4478-9c52-bca8cada4ac8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The document presents data on TScan Therapeutics' progress, including in vitro studies and discovery process.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a process flow to explain patient stratification for a clinical trial.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/27", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-27", "loopMatches": [], "arcBeatMatches": [ { "to": 35, "from": 24, "beatId": "63bd9bf8-a080-4478-9c52-bca8cada4ac8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The document presents data on TScan Therapeutics' progress, including in vitro studies and discovery process.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/28", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-28", "loopMatches": [], "arcBeatMatches": [ { "to": 35, "from": 24, "beatId": "63bd9bf8-a080-4478-9c52-bca8cada4ac8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The document presents data on TScan Therapeutics' progress, including in vitro studies and discovery process.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "solution", "function": "present_solution", "notes": "Uses a Venn diagram to show overlap in Head & Neck cancers, and a central 'ImmunoBank' repository feeding into multiplexed TCR-T arms.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/29", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-29", "loopMatches": [], "arcBeatMatches": [ { "to": 35, "from": 24, "beatId": "63bd9bf8-a080-4478-9c52-bca8cada4ac8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The document presents data on TScan Therapeutics' progress, including in vitro studies and discovery process.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide highlights target expression overlap to justify multiplexed therapy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/30", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-30", "loopMatches": [], "arcBeatMatches": [ { "to": 35, "from": 24, "beatId": "63bd9bf8-a080-4478-9c52-bca8cada4ac8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The document presents data on TScan Therapeutics' progress, including in vitro studies and discovery process.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "traction", "function": "show_traction", "notes": "The chart shows fold-enrichment of protein fragments, highlighting a 'Novel Head & Neck Target' alongside positive controls.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/31", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-31", "loopMatches": [], "arcBeatMatches": [ { "to": 35, "from": 24, "beatId": "63bd9bf8-a080-4478-9c52-bca8cada4ac8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The document presents data on TScan Therapeutics' progress, including in vitro studies and discovery process.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "solution", "function": "present_solution", "notes": "The chart shows fold-enrichment of protein fragments, highlighting three specific targets identified from patient data.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/32", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-32", "loopMatches": [], "arcBeatMatches": [ { "to": 35, "from": 24, "beatId": "63bd9bf8-a080-4478-9c52-bca8cada4ac8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The document presents data on TScan Therapeutics' progress, including in vitro studies and discovery process.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "solution", "function": "present_solution", "notes": "The chart uses a log scale on the y-axis to compare expression levels across multiple tissue types.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/33", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-33", "loopMatches": [], "arcBeatMatches": [ { "to": 35, "from": 24, "beatId": "63bd9bf8-a080-4478-9c52-bca8cada4ac8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The document presents data on TScan Therapeutics' progress, including in vitro studies and discovery process.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "product_demo", "function": "show_traction", "notes": "Slide 34 from TScan Therapeutics deck.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/34", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-34", "loopMatches": [], "arcBeatMatches": [ { "to": 35, "from": 24, "beatId": "63bd9bf8-a080-4478-9c52-bca8cada4ac8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The document presents data on TScan Therapeutics' progress, including in vitro studies and discovery process.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a process flow to demonstrate the company's R&D pipeline progress.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/35", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-35", "loopMatches": [], "arcBeatMatches": [ { "to": 35, "from": 24, "beatId": "63bd9bf8-a080-4478-9c52-bca8cada4ac8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The document presents data on TScan Therapeutics' progress, including in vitro studies and discovery process.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a process flow to explain the mechanism of action for the company's platform.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/36", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-36", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/37", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-37", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a diagram to illustrate the mechanism of the T-Integrate system (transposon/transposase integration into T cell DNA).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/38", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-38", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "other", "function": "plan_implementation", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/39", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-39", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 40, "slideType": "business_model", "function": "present_solution", "notes": "Uses a honeycomb/hexagonal diagram to represent the three focus areas.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/40", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-40", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 41, "slideType": "other", "function": "other", "notes": "The slide highlights a specific partnership deal structure.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/41", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-41", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 42, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a hexagonal diagram to represent disease areas (Oncology, Infectious Disease, Autoimmune Disease).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/42", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-42", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4ec1-761e-bce7-779cb9a1fe78", "docSlug": "bd64755c9d094dce862ec77cfb2b1978", "documentTitle": "TScan Therapeutics | IPO Presentation Deck | 43 slides", "authorId": "tscan-therapeutics", "authorName": "TScan Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 43, "slideType": "executive_summary", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4ec1-761e-bce7-779cb9a1fe78/43", "deckHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78", "deckAnchorHref": "/decks/019de071-4ec1-761e-bce7-779cb9a1fe78#slide-43", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4f61-772a-8b75-32fff1ff280b", "docSlug": "7d6267c1e03487ae13b586df0ddbb036", "documentTitle": "UBS | Results Presentation Deck | 27 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/QpAyzGa1Qd18Szeupj0ut4jtY9FTW19Q2mQQvU8sUOA/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83ZDYyNjdjMWUwMzQ4N2FlMTNiNTg2ZGYwZGRiYjAzNi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4f61-772a-8b75-32fff1ff280b/1", "deckHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b", "deckAnchorHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "61824e1a-dc67-4634-86ad-981771f1921f", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The deck starts with an overview of key messages and highlights", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/414T-6rucQ0joTDTaFl43VOtbrVyTsAysAw4LZePmM4/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83ZDYyNjdjMWUwMzQ4N2FlMTNiNTg2ZGYwZGRiYjAzNi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/sphky-xpo6ErxLwVfwO5IXJQxIPmdb40rjYloeouwKM/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83ZDYyNjdjMWUwMzQ4N2FlMTNiNTg2ZGYwZGRiYjAzNi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/Fyin4GvMZ-wUkVVanFGzKRP97m2NnvzPmWdO4pb2Otg/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83ZDYyNjdjMWUwMzQ4N2FlMTNiNTg2ZGYwZGRiYjAzNi9wMDAxLnBuZw" }, { "docId": "019de071-4f61-772a-8b75-32fff1ff280b", "docSlug": "7d6267c1e03487ae13b586df0ddbb036", "documentTitle": "UBS | Results Presentation Deck | 27 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4f61-772a-8b75-32fff1ff280b/2", "deckHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b", "deckAnchorHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "61824e1a-dc67-4634-86ad-981771f1921f", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The deck starts with an overview of key messages and highlights", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4f61-772a-8b75-32fff1ff280b", "docSlug": "7d6267c1e03487ae13b586df0ddbb036", "documentTitle": "UBS | Results Presentation Deck | 27 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 3, "slideType": "agenda", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4f61-772a-8b75-32fff1ff280b/3", "deckHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b", "deckAnchorHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "61824e1a-dc67-4634-86ad-981771f1921f", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The deck starts with an overview of key messages and highlights", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4f61-772a-8b75-32fff1ff280b", "docSlug": "7d6267c1e03487ae13b586df0ddbb036", "documentTitle": "UBS | Results Presentation Deck | 27 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 4, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4f61-772a-8b75-32fff1ff280b/4", "deckHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b", "deckAnchorHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 1, "beatId": "61824e1a-dc67-4634-86ad-981771f1921f", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The deck starts with an overview of key messages and highlights", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4f61-772a-8b75-32fff1ff280b", "docSlug": "7d6267c1e03487ae13b586df0ddbb036", "documentTitle": "UBS | Results Presentation Deck | 27 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 5, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a combination of bar charts for period-over-period comparison and circular callouts for net new growth metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4f61-772a-8b75-32fff1ff280b/5", "deckHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b", "deckAnchorHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b#slide-5", "loopMatches": [ { "to": 16, "from": 5, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "3032569d-a560-44bc-bb8e-3c5b00bab572", "evidence": "The deck presents a clear chain of logic connecting strategy to results", "position": 0, "objective": "How UBS's strategy is driving growth and efficiency", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 8, "from": 5, "beatId": "518bd0cf-dcef-442d-ba59-712c016a66c5", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The deck presents an overview of the bank's ecosystem and growth strategy", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4f61-772a-8b75-32fff1ff280b", "docSlug": "7d6267c1e03487ae13b586df0ddbb036", "documentTitle": "UBS | Results Presentation Deck | 27 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 6, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a combination of bar charts for historical comparison and big-number metrics for recent period performance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4f61-772a-8b75-32fff1ff280b/6", "deckHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b", "deckAnchorHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b#slide-6", "loopMatches": [ { "to": 16, "from": 5, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "3032569d-a560-44bc-bb8e-3c5b00bab572", "evidence": "The deck presents a clear chain of logic connecting strategy to results", "position": 0, "objective": "How UBS's strategy is driving growth and efficiency", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 8, "from": 5, "beatId": "518bd0cf-dcef-442d-ba59-712c016a66c5", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The deck presents an overview of the bank's ecosystem and growth strategy", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4f61-772a-8b75-32fff1ff280b", "docSlug": "7d6267c1e03487ae13b586df0ddbb036", "documentTitle": "UBS | Results Presentation Deck | 27 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 7, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a waterfall-style bridge to show total invested assets growth from 30.6.20 to 30.6.21.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4f61-772a-8b75-32fff1ff280b/7", "deckHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b", "deckAnchorHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b#slide-7", "loopMatches": [ { "to": 16, "from": 5, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "3032569d-a560-44bc-bb8e-3c5b00bab572", "evidence": "The deck presents a clear chain of logic connecting strategy to results", "position": 0, "objective": "How UBS's strategy is driving growth and efficiency", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 8, "from": 5, "beatId": "518bd0cf-dcef-442d-ba59-712c016a66c5", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The deck presents an overview of the bank's ecosystem and growth strategy", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4f61-772a-8b75-32fff1ff280b", "docSlug": "7d6267c1e03487ae13b586df0ddbb036", "documentTitle": "UBS | Results Presentation Deck | 27 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 8, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The table uses a grouped layout by business unit with specific columns for period-over-period comparison and target/guidance benchmarks.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4f61-772a-8b75-32fff1ff280b/8", "deckHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b", "deckAnchorHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b#slide-8", "loopMatches": [ { "to": 16, "from": 5, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "3032569d-a560-44bc-bb8e-3c5b00bab572", "evidence": "The deck presents a clear chain of logic connecting strategy to results", "position": 0, "objective": "How UBS's strategy is driving growth and efficiency", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 8, "from": 5, "beatId": "518bd0cf-dcef-442d-ba59-712c016a66c5", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The deck presents an overview of the bank's ecosystem and growth strategy", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4f61-772a-8b75-32fff1ff280b", "docSlug": "7d6267c1e03487ae13b586df0ddbb036", "documentTitle": "UBS | Results Presentation Deck | 27 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 9, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Waterfall chart shows the bridge from 2Q20 to 2Q21 profit before tax.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4f61-772a-8b75-32fff1ff280b/9", "deckHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b", "deckAnchorHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b#slide-9", "loopMatches": [ { "to": 16, "from": 5, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "3032569d-a560-44bc-bb8e-3c5b00bab572", "evidence": "The deck presents a clear chain of logic connecting strategy to results", "position": 0, "objective": "How UBS's strategy is driving growth and efficiency", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 16, "from": 9, "beatId": "11a47caa-f67a-407c-84b3-4dd947506b48", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The deck provides detailed financial results and highlights achievements", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4f61-772a-8b75-32fff1ff280b", "docSlug": "7d6267c1e03487ae13b586df0ddbb036", "documentTitle": "UBS | Results Presentation Deck | 27 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 10, "slideType": "other", "function": "analyze_data", "notes": "The chart illustrates the movement from 11.7bn to 12.8bn in operating expenses.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4f61-772a-8b75-32fff1ff280b/10", "deckHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b", "deckAnchorHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b#slide-10", "loopMatches": [ { "to": 16, "from": 5, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "3032569d-a560-44bc-bb8e-3c5b00bab572", "evidence": "The deck presents a clear chain of logic connecting strategy to results", "position": 0, "objective": "How UBS's strategy is driving growth and efficiency", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 16, "from": 9, "beatId": "11a47caa-f67a-407c-84b3-4dd947506b48", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The deck provides detailed financial results and highlights achievements", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4f61-772a-8b75-32fff1ff280b", "docSlug": "7d6267c1e03487ae13b586df0ddbb036", "documentTitle": "UBS | Results Presentation Deck | 27 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 11, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide highlights 2Q21 performance metrics compared to historical trends.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4f61-772a-8b75-32fff1ff280b/11", "deckHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b", "deckAnchorHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b#slide-11", "loopMatches": [ { "to": 16, "from": 5, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "3032569d-a560-44bc-bb8e-3c5b00bab572", "evidence": "The deck presents a clear chain of logic connecting strategy to results", "position": 0, "objective": "How UBS's strategy is driving growth and efficiency", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 16, "from": 9, "beatId": "11a47caa-f67a-407c-84b3-4dd947506b48", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The deck provides detailed financial results and highlights achievements", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4f61-772a-8b75-32fff1ff280b", "docSlug": "7d6267c1e03487ae13b586df0ddbb036", "documentTitle": "UBS | Results Presentation Deck | 27 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 12, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes a waterfall-style comparison of growth between 2Q20 and 2Q21.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4f61-772a-8b75-32fff1ff280b/12", "deckHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b", "deckAnchorHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b#slide-12", "loopMatches": [ { "to": 16, "from": 5, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "3032569d-a560-44bc-bb8e-3c5b00bab572", "evidence": "The deck presents a clear chain of logic connecting strategy to results", "position": 0, "objective": "How UBS's strategy is driving growth and efficiency", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 16, "from": 9, "beatId": "11a47caa-f67a-407c-84b3-4dd947506b48", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The deck provides detailed financial results and highlights achievements", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4f61-772a-8b75-32fff1ff280b", "docSlug": "7d6267c1e03487ae13b586df0ddbb036", "documentTitle": "UBS | Results Presentation Deck | 27 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 13, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes footnote regarding 4Q19 asset/loan shift.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4f61-772a-8b75-32fff1ff280b/13", "deckHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b", "deckAnchorHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b#slide-13", "loopMatches": [ { "to": 16, "from": 5, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "3032569d-a560-44bc-bb8e-3c5b00bab572", "evidence": "The deck presents a clear chain of logic connecting strategy to results", "position": 0, "objective": "How UBS's strategy is driving growth and efficiency", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 16, "from": 9, "beatId": "11a47caa-f67a-407c-84b3-4dd947506b48", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The deck provides detailed financial results and highlights achievements", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4f61-772a-8b75-32fff1ff280b", "docSlug": "7d6267c1e03487ae13b586df0ddbb036", "documentTitle": "UBS | Results Presentation Deck | 27 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 14, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a stacked bar chart to show asset composition over time, with a callout box summarizing recent NNFGA performance and margin drivers.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4f61-772a-8b75-32fff1ff280b/14", "deckHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b", "deckAnchorHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b#slide-14", "loopMatches": [ { "to": 16, "from": 5, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "3032569d-a560-44bc-bb8e-3c5b00bab572", "evidence": "The deck presents a clear chain of logic connecting strategy to results", "position": 0, "objective": "How UBS's strategy is driving growth and efficiency", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 16, "from": 9, "beatId": "11a47caa-f67a-407c-84b3-4dd947506b48", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The deck provides detailed financial results and highlights achievements", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4f61-772a-8b75-32fff1ff280b", "docSlug": "7d6267c1e03487ae13b586df0ddbb036", "documentTitle": "UBS | Results Presentation Deck | 27 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 15, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Waterfall-style comparison of PBT and Operating Income components over five quarters.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4f61-772a-8b75-32fff1ff280b/15", "deckHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b", "deckAnchorHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b#slide-15", "loopMatches": [ { "to": 16, "from": 5, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "3032569d-a560-44bc-bb8e-3c5b00bab572", "evidence": "The deck presents a clear chain of logic connecting strategy to results", "position": 0, "objective": "How UBS's strategy is driving growth and efficiency", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 16, "from": 9, "beatId": "11a47caa-f67a-407c-84b3-4dd947506b48", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The deck provides detailed financial results and highlights achievements", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4f61-772a-8b75-32fff1ff280b", "docSlug": "7d6267c1e03487ae13b586df0ddbb036", "documentTitle": "UBS | Results Presentation Deck | 27 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 16, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a waterfall-bridge style visualization to show the impact of the Fondcenter sale on PBT and Operating income.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4f61-772a-8b75-32fff1ff280b/16", "deckHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b", "deckAnchorHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b#slide-16", "loopMatches": [ { "to": 16, "from": 5, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "3032569d-a560-44bc-bb8e-3c5b00bab572", "evidence": "The deck presents a clear chain of logic connecting strategy to results", "position": 0, "objective": "How UBS's strategy is driving growth and efficiency", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 16, "from": 9, "beatId": "11a47caa-f67a-407c-84b3-4dd947506b48", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The deck provides detailed financial results and highlights achievements", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4f61-772a-8b75-32fff1ff280b", "docSlug": "7d6267c1e03487ae13b586df0ddbb036", "documentTitle": "UBS | Results Presentation Deck | 27 slides", "authorId": "ubs", "authorName": "UBS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 17, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes a breakdown of Global Markets and Global Banking revenues, plus key metrics like RoAE, RWA, and LRD.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4f61-772a-8b75-32fff1ff280b/17", "deckHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b", "deckAnchorHref": "/decks/019de071-4f61-772a-8b75-32fff1ff280b#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }